Overview

BAY 0 9867 Cipro Pediatric Use Study (QUIP)

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Objective and subjective musculoskeletal evaluations will be performed to determine differences in the ciprofloxacin versus non-quinolone treated pediatric patients so that we can tell what the natural occurrence of such musculoskeletal conditions is in the general pediatric population.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ciprofloxacin